Hepregen
Biotechnology company that focuses on understanding the metabolism of drugs in the liver.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD16—25m (Dealroom.co estimates Sep 2008.)
Medford Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$3.0m | Series A | ||
| N/A | $50.0k | Grant | |
$500k | Grant | ||
$500k | Grant | ||
| N/A | $500k | Grant | |
| Total Funding | CAD6.2m | ||
Recent News about Hepregen
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.